Picton Mahoney Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$390K Buy
694
+169
+32% +$108K ﹤0.01% 793
2025
Q4
$355K Buy
+525
New +$358K ﹤0.01% 762
2020
Q1
Sell
-38,600
Closed -$10.1M 322
2019
Q4
$10.1M Sell
38,600
-8,700
-18% -$2.29M 0.68% 52
2019
Q3
$12.9M Sell
47,300
-3,200
-6% -$890K 0.91% 39
2019
Q2
$13.9M Sell
50,500
-1,300
-3% -$320K 0.95% 38
2019
Q1
$11.6M Sell
51,800
-1,000
-2% -$206K 0.88% 43
2018
Q4
$9.82M Sell
52,800
-10,700
-17% -$2.19M 0.88% 43
2018
Q3
$15.9M Sell
63,500
-2,100
-3% -$510K 1.11% 30
2018
Q2
$14.3M Buy
65,600
+30,200
+85% +$6.22M 1.03% 36
2018
Q1
$6.78M Buy
+35,400
New +$6.53M 0.49% 70

Other funds holding IDXX

Picton Mahoney Asset Management's IDXX Position: Q1 2026 in Review

Picton Mahoney Asset Management increased its Idexx Laboratories (IDXX) stake by 32% in Q1 2026, buying an estimated $108K and bringing the position to 694 shares worth $390K. The position accounts for ﹤0.01% of the portfolio, ranked #793.

Picton Mahoney Asset Management first reported a position in IDXX in Q1 2018 and has held it in 10 quarters since. The position peaked at $15.9M in Q3 2018. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Picton Mahoney Asset Management held 694 shares of Idexx Laboratories worth $390K as of Q1 2026.
  • Picton Mahoney Asset Management bought 169 Idexx Laboratories shares in Q1 2026, an estimated $108K.
  • Idexx Laboratories made up ﹤0.01% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #793 holding.
  • Picton Mahoney Asset Management first reported a position in Idexx Laboratories in Q1 2018 and has held it in 10 quarters since.
  • Picton Mahoney Asset Management's Idexx Laboratories position peaked at $15.9M in Q3 2018.
  • 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.